You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Douglas Steinhauff1, Blair Armstrong1, Mark Martin Jensen1
1Department of Biomedical Engineering, University of Utah, 36 S. Wasatch Dr., Salt Lake City, UT, 84112, USA.
Researchers engineered stimuli-responsive elastin-like polypeptide (ELP) fusion proteins. These ELP subunits, when conjugated with Rituximab, effectively target CD20 receptors on B cells, enhancing therapeutic potential.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: